Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1990 Jan 4;322(1):1-6.
doi: 10.1056/NEJM199001043220101.

Leukemia following chemotherapy for ovarian cancer

J M Kaldor  1 , N E Day, F Pettersson, E A Clarke, D Pedersen, W Mehnert, J Bell, H Høst, P Prior, S Karjalainen, et al.
Affiliations
Free article
Clinical Trial

Leukemia following chemotherapy for ovarian cancer

J M Kaldor et al. N Engl J Med. .
Free article

Abstract

An international collaborative group of cancer registries and hospitals identified 114 cases of leukemia following ovarian cancer. We investigated the possible etiologic role of chemotherapy, radiotherapy, and other factors, using a case-control study design, with three controls matched to each case of leukemia. Chemotherapy alone was associated with a relative risk of 12 (95 percent confidence interval, 4.4 to 32), as compared with surgery alone, and patients treated with both chemotherapy and radiotherapy had a relative risk of 10 (95 percent confidence interval, 3.4 to 28). Radiotherapy alone did not produce a significant increase in risk as compared with surgery alone. The risk of leukemia was greatest four or five years after chemotherapy began, and the risk was elevated for at least eight years after the cessation of chemotherapy. The drugs cyclophosphamide, chlorambucil, melphalan, thiotepa, and treosulfan were independently associated with significantly increased risks of leukemia, as was the combination of doxorubicin hydrochloride and cisplatin. Chlorambucil and melphalan were the most leukemogenic drugs, followed by thiotepa; cyclophosphamide and treosulfan were the weakest leukemogens, and the effect per gram was substantially lower at high doses than at lower doses. The extent to which the relative risks of leukemia are offset by differences in chemotherapeutic effectiveness is not known.

PubMed Disclaimer

Comment in

  • Treatment-related leukemia.
    Coltman CA Jr, Dahlberg S. Coltman CA Jr, et al. N Engl J Med. 1990 Jan 4;322(1):52-3. doi: 10.1056/NEJM199001043220109. N Engl J Med. 1990. PMID: 2294417 No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms

LinkOut - more resources